Frost & Sullivan analysis concludes that OmniActive Health Technologies’ proprietary product, Lutemax 2020, addresses industry challenges by offering eye, skin and brain health benefits from a single, convenient ingredient. The company also created strong visibility in the market through campaigns depicting the health benefits of all three macular carotenoids – luetin, RR-zeaxanthin and RS (meso)-zeaxanthin. Through consistent investments in research and development, this company broadens its scientific substantiation on eye-health ingredients and focuses on new studies that support bioavailability and visual function, and , more importantly, emphasize the benefits of supplementation with macular carotenoids from Lutemax 2020 to support eyes during prolonged exposure to digital screens.
“To provide eyes with superior nutrient availability, OmniActive Health Technologies’ unique Lutemax 2020 formulation delivers lutein and zeaxanthin isomers – all from a single ingredient. Frost & Sullivan points out that this is a key differentiator among other competitors in the market.”